Hepatocyte growth factor activates Wnt pathway by transcriptional activation of LEF1 to facilitate tumor invasion

Carcinogenesis

Volumn 33, Issue 6, 2012, Pages 1142-1148

  Huang, Fang I ^a   Chen, Yu Ling ^a,b   Chang, Chih Ning ^a   Yuan, Ray Hwang ^b   Jeng, Yung Ming ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; HOMEODOMAIN PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOID ENHANCER FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SCATTER FACTOR; TRANSCRIPTION FACTOR SLUG; UNCLASSIFIED DRUG; WNT PROTEIN; ZINC FINGER E BOX BINDING HOMEOBOX 2 PROTEIN;

ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CELL MIGRATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; GENE OVEREXPRESSION; GENE SILENCING; IMMUNOHISTOCHEMISTRY; LIVER CANCER; MICROARRAY ANALYSIS; PRIORITY JOURNAL; TRANSCRIPTION INITIATION; WNT SIGNALING PATHWAY;

BETA CATENIN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; HEK293 CELLS; HEP G2 CELLS; HEPATOCYTE GROWTH FACTOR; HOMEODOMAIN PROTEINS; HUMANS; LIVER NEOPLASMS; LYMPHOID ENHANCER-BINDING FACTOR 1; NEOPLASM INVASIVENESS; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASE; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MET; REPRESSOR PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; WNT SIGNALING PATHWAY;

EID: 84864320039     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs131     Document Type: Article

References (40)

1. Desiderio, M.A. (2007) Hepatocyte growth factor in invasive growth of carcinomas. Cell Mol. Life Sci., 64, 1341-1354.
2. Matsumoto, K. et al. (2006) Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions. Int. J. Cancer, 119, 477-483.
3. Kim, C.H. et al. (2010) c-Met expression as an indicator of survival outcome in patients with oral tongue carcinoma. Head Neck, 32, 1655-1664.
4. Jeanes, A. et al. (2008) Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene, 27, 6920-6929.
5. Rubinfeld, B. et al. (1993) Association of the APC gene product with β-catenin. Science, 262, 1731-1734.
6. Behrens, J. et al. (1996) Functional interaction of β-catenin with the transcription factor LEF-1. Nature, 382, 638-642.
7. Nishisho, I. et al. (1991) Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science, 253, 665-669.
8. Fukuchi, T. et al. (1998) β-catenin mutation in carcinoma of the uterine endometrium. Cancer Res., 58, 3526-3528.
9. Hsu, H.C. et al. (2000) β-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis. Am. J. Pathol., 157, 763-770.
10. Müller, T. et al. (1999) Phosphorylation and free pool of β-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration. J. Biol. Chem., 274, 10173-10183.
11. Papkoff, J. et al. (1998) WNT-1 and HGF regulate GSK3β activity and b-catenin signaling in mammary epithelial cells. Biochem. Biophys. Res. Commun., 247, 851-858.
12. Travis, A. et al. (1991) LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor α enhancer function. Genes Dev., 5, 880-894.
13. Barker, N. et al. (1999) Restricted high level expression of TCF-4 protein in intestinal and mammary gland epithelium. Am. J. Pathol., 154, 29-35.
14. Korinek, V. et al. (1998) Depletion of epithelial stem-cell compartments in the small intestine of mice lacking TCF-4. Nat. Genet., 19, 379-383.
15. van de Wetering, M. et al. (1999) Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box. EMBO J., 10, 123-132.
16. Kriegl, L. et al. (2010) LEF-1 and TCF4 expression correlate inversely with survival in colorectal cancer. J. Transl. Med., 8, 123.
17. Nguyen, A. et al. (2005) Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression. Int. J. Oncol., 27, 949-956.
18. Kim, K. et al. (2002) Direct evidence for a role of b-catenin/LEF-1 signaling pathway in induction of EMT. Cell Biol. Int., 26, 463-476.
19. Filali, M. et al. (2002) Wnt-3A/β-catenin signaling induces transcription from the LEF-1 promoter. J. Biol. Chem., 277, 33398-33410.
20. Spix, J.K. et al. (2007) Hepatocyte growth factor induces epithelial cell motility through transactivation of the epidermal growth factor receptor. Exp. Cell Res., 313, 3319-3325.
21. Monvoisin, A. et al. (2002) Involvement of matrix metalloproteinase type-3 in hepatocyte growth factor-induced invasion of human hepatocellular carcinoma cells. Int. J. Cancer, 97, 157-162.
22. Unger, B.L. et al. (2011) Hepatocyte growth factor and keratinocyte growth factor enhance IL-1-induced IL-8 secretion through different mechanisms in Caco-2 epithelial cells. In Vitro Cell Dev. Biol. Anim., 47, 173-181.
23. Gaggioli, C. et al. (2005) HGF induces fibronectin matrix synthesis in melanoma cells through MAP kinase-dependent signaling pathway and induction of Egr-1. Oncogene, 24, 1423-1433.
24. David, M.D. et al. (2008) Signalling by neurotrophins and hepatocyte growth factor regulates axon morphogenesis by differential β-catenin phosphorylation. J. Cell Sci., 121, 2718-2730.
25. Apte, U. et al. (2006) Activation of Wnt/β-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice. Hepatology, 44, 992- 1002.
26. Liou, G.I. et al. (2002) MAP kinase and β-catenin signaling in HGF induced RPE migration. Mol. Vis., 8, 483-493.
27. de La Coste, A. et al. (1998) Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl. Acad. Sci. USA, 95, 8847-8851.
28. Yu, C.F. et al. (2001) ERK regulates the hepatocyte growth factor-mediated interaction of Gab1 and the phosphatidylinositol 3-kinase. J. Biol. Chem., 276, 32552-32558.
29. Zeng, Q. et al. (2002) Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFjB. J. Biol. Chem., 277, 25203- 25208.
30. Schulze-Bergkamen, H. et al. (2004) Hepatocyte growth factor induces Mcl-1 in primary human hepatocytes and inhibits CD95-mediated apoptosis via Akt. Hepatology, 39, 645-654.
31. Kane, L.P. et al. (1999) Induction of NF-kappaB by the Akt/PKB kinase. Curr. Biol., 9, 601-604.
32. Bremnes, R.M. et al. (2011) The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and nonsmall cell lung cancer. J. Thorac. Oncol., 6, 209-217.
33. Monga, S.P. et al. (2002) Hepatocyte growth factor induces Wnt-independent nuclear translocation of β-catenin after Met-b-catenin dissociation in hepatocytes. Cancer Res., 62, 2064-2071.
34. Vermeulen, L. et al. (2010) Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat. Cell Biol., 12, 468-476.
35. Geyer, F.C. et al. (2011) β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation. Mod. Pathol., 24, 209-231.
36. Nguyen, D.X. et al. (2009) WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell, 138, 51-62.
37. Li, Y. et al. (2009) LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion. Cancer Res., 69, 3332-3338.
38. Lambertini, E. et al. (2010) SLUG: a new target of lymphoid enhancer factor-1 in human osteoblasts. BMC Mol. Biol., 11, 13.
39. Sakai, D. et al. (2005) Regulation of Slug transcription in embryonic ectoderm by β-catenin-Lef/Tcf and BMP-Smad signaling. Dev. Growth Differ., 47, 471-482.
40. Yun, K. et al. (2007) NF-κB regulates Lef1 gene expression in chondrocytes. Biochem. Biophys. Res. Commun., 357, 589-595.